163 related articles for article (PubMed ID: 15833550)
1. Influence of estradiol pretreatment on antimuscarinic action of oxybutynin in rat detrusor muscle.
Yildiz O; Ozgok Y; Seyrek M; Un I; Kilciler M; Tuncer M
Urology; 2005 Apr; 65(4):800-3. PubMed ID: 15833550
[TBL] [Abstract][Full Text] [Related]
2. Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland.
Waldeck K; Larsson B; Andersson KE
J Urol; 1997 Mar; 157(3):1093-7. PubMed ID: 9072550
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of solifenacin on human isolated urinary bladder.
Masunaga K; Yoshida M; Inadome A; Murakami S; Sugiyama Y; Satoji Y; Maeda Y; Ueda S
Pharmacology; 2008; 82(1):43-52. PubMed ID: 18434763
[TBL] [Abstract][Full Text] [Related]
4. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
Kim Y; Yoshimura N; Masuda H; De Miguel F; Chancellor MB
BJU Int; 2006 Feb; 97(2):400-3. PubMed ID: 16430654
[TBL] [Abstract][Full Text] [Related]
5. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
[TBL] [Abstract][Full Text] [Related]
6. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
[TBL] [Abstract][Full Text] [Related]
7. Bryophyllum pinnatum inhibits detrusor contractility in porcine bladder strips--a pharmacological study towards a new treatment option of overactive bladder.
Schuler V; Suter K; Fürer K; Eberli D; Horst M; Betschart C; Brenneisen R; Hamburger M; Mennet M; Schnelle M; Simões-Wüst AP; von Mandach U
Phytomedicine; 2012 Jul; 19(10):947-51. PubMed ID: 22824522
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of sex hormones and phytoestrogens on peak and steady state contractions in isolated rabbit detrusor.
Ratz PH; McCammon KA; Altstatt D; Blackmore PF; Shenfeld OZ; Schlossberg SM
J Urol; 1999 Nov; 162(5):1821-8. PubMed ID: 10524942
[TBL] [Abstract][Full Text] [Related]
9. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats.
Ohtake A; Ukai M; Hatanaka T; Kobayashi S; Ikeda K; Sato S; Miyata K; Sasamata M
Eur J Pharmacol; 2004 May; 492(2-3):243-50. PubMed ID: 15178371
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term oxybutynin administration on c-Fos expression in spinal neurons: inhibition of antimuscarinics on bladder afferents in conscious rats.
Haga N; Aikawa K; Shishido K; Takahashi N; Yanagida T; Yamaguchi O
Urology; 2009 Jan; 73(1):200-4. PubMed ID: 18561989
[TBL] [Abstract][Full Text] [Related]
12. The effects of ovariectomy and estrogen replacement on acetylcholine release from nerve fibres and passive stretch-induced acetylcholine release in female rat bladder.
Yoshida J; Aikawa K; Yoshimura Y; Shishido K; Yanagida T; Yamaguchi O
Neurourol Urodyn; 2007; 26(7):1050-5. PubMed ID: 17480029
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats.
Sugiyama Y; Yoshida M; Masunaga K; Satoji Y; Maeda Y; Nagata T; Inadome A; Ueda S
Int J Urol; 2008 Jan; 15(1):76-81. PubMed ID: 18184179
[TBL] [Abstract][Full Text] [Related]
14. Effects of the anticholinergic drug prifinium bromide on urinary bladder contractions in rat in vivo and in guinea-pig in vitro.
Terai T; Deguchi Y; Ohtsuka M; Kumada S
Arzneimittelforschung; 1991 Apr; 41(4):417-20. PubMed ID: 1677577
[TBL] [Abstract][Full Text] [Related]
15. Actions of the new antimuscarinic compound Lu 25-109 on isolated human and pig detrusor.
Waldeck K; Larsson B; Sandberg B; Andersson K-
Neurourol Urodyn; 2002; 21(1):92-8. PubMed ID: 11835429
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the antimuscarinic and antispasmodic actions of racemic oxybutynin and desethyloxybutynin and their enantiomers with those of racemic terodiline.
Smith ER; Wright SE; Aberg G; Fang Y; McCullough JR
Arzneimittelforschung; 1998 Oct; 48(10):1012-8. PubMed ID: 9825119
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE
BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452
[TBL] [Abstract][Full Text] [Related]
18. Relaxant effects of estradiol through non-genomic pathways in male and female pig bladder smooth muscle.
Dambros M; van Koeveringe GA; Bast A; van Kerrebroeck PE
Pharmacology; 2004 Oct; 72(2):121-7. PubMed ID: 15331918
[TBL] [Abstract][Full Text] [Related]
19. Direct inhibition of rat detrusor muscle contraction by erythromycin.
England RC; Norman RI; Elliott RA
Neurourol Urodyn; 2004; 23(3):273-9. PubMed ID: 15098226
[TBL] [Abstract][Full Text] [Related]
20. Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat.
Aizawa N; Homma Y; Igawa Y
Neurourol Urodyn; 2015 Apr; 34(4):368-74. PubMed ID: 24532414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
